Background: Cutaneous Rosai-Dorfman disease is a rare disorder belonging to the spectrum of non-Langerhans cell histiocytoses. It is characterized by dermal and subcutaneous infiltrates of histiocytes as well as accompanying lymphocytes, plasma cells and granulocytes. Because it is so rare, standard therapies have not been established.
Case Report: A 27-year-old man showed an excellent response to intralesional corticosteroids after unsuccessful prior treatment with methotrexate, systemic steroids and surgery as well as laser therapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00105-014-2797-0 | DOI Listing |
Arch Dermatol Res
December 2024
Department of Dermatology, Charles Nicolle Hospital, Tunis, Tunisia.
Int J Dermatol
November 2024
Department of Dermatology, Charles Nicolle Hospital, Tunis, Tunisia.
An Bras Dermatol
November 2024
Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Electronic address:
SAGE Open Med Case Rep
October 2024
Division of Dermatology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!